A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome

A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome

<p>Abstract</p> <p>The regimen of cytarabine, aclarubicin and G-CSF (CAG) has been widely used in China and Japan for treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). We searched literature on CAG between 1995 and 2010 and performed a meta-analysis to d...

Full description

Bibliographic Details
Main Authors: Wei Guoqing, Ni Wanmao, Chiao Jen-wei, Cai Zhen, Huang He, Liu Delong
Format: Article
Language:English
Published: BMC 2011-11-01
Series:Journal of Hematology & Oncology
Subjects:
acute myeloid leukemia
myelodysplastic syndrome
CAG
aclarubicin
meta-analysis
Online Access:http://www.jhoonline.org/content/4/1/46

Internet

http://www.jhoonline.org/content/4/1/46

Similar Items